XML 13 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Statement of Comprehensive Income [Abstract]        
Net loss $ (6,626) $ (5,682) $ (10,852) $ (13,745)
Available for sale securities - net unrealized gain (loss) 126 (4) 0 (4)
Total other comprehensive gain (loss) 126 (4) 0 (4)
Comprehensive loss attributable to Caladrius Biosciences, Inc. common stockholders $ (6,500) $ (5,686) $ (10,852) $ (13,749)